Why Abbott’s vascular team sees AI as the GPS for the cath lab
In this episode of AbbottTalks, Hosts Tom Salemi and Kayleen Brown sit down with Ethan Korngold, MD, Divisional Vice President, Medical Affairs and Chief Medical Officer of Abbott’s Vascular business, to discuss how artificial intelligence is reshaping decision-making in the cath lab and beyond. Dr. Korngold, an interventional cardiologist turned MedTech leader, discusses the evolution of Abbott’s vascular portfolio and how the company is integrating AI through platforms like Ultreon 2.0 to improve outcomes and procedural efficiency.
The conversation covers specific applications of AI in intravascular imaging, vessel sizing, calcium detection, and future steps in stent placement guidance. He also addresses physician and hospital system perceptions of AI, why he sees it as a GPS-like tool for guiding physicians through complex procedures, and how it may soon impact pre- and post-procedural care.
This episode is brought to you by Resonetics. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8
Want to understand the history of nitinol? Make sure to check out Eric’s Veit’s Nitinol Innovation: Decade-by-Decade breakdown on LinkedIn: https://www.linkedin.com/
WATCH:
LISTEN:
***
Enjoy this podcast? Follow AbbottTalks on all major podcast players: https://abbotttalks.castos.com/ Subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
